Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · IEX Real-Time Price · USD
43.52
+0.31 (0.72%)
At close: Mar 27, 2024, 4:00 PM
43.56
+0.04 (0.09%)
Pre-market: Mar 28, 2024, 7:00 AM EDT

Amphastar Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2011
Revenue
644.4498.99437.77349.85322.36294.67240.18255.17251.52210.46
Upgrade
Revenue Growth (YoY)
29.14%13.98%25.13%8.53%9.40%22.69%-5.87%1.45%19.51%-8.37%
Upgrade
Cost of Revenue
293.27250.13238.03206.51190.43187.68149.67150.97174.17159.21
Upgrade
Gross Profit
351.12248.86199.74143.34131.92106.9990.51104.277.3551.26
Upgrade
Selling, General & Admin
80.3966.5968.9265.1663.1158.0450.9247.346.9740.37
Upgrade
Research & Development
73.7474.7760.9367.2368.8557.5643.541.5237.2728.87
Upgrade
Other Operating Expenses
000000-2.64000
Upgrade
Operating Expenses
154.13141.36129.85132.39131.96115.6191.7888.8284.2569.24
Upgrade
Operating Income
196.99107.569.8910.95-0.04-8.62-1.2715.38-6.9-17.98
Upgrade
Interest Expense / Income
27.161.850.890.370.120.240.831.020.990.61
Upgrade
Other Expense / Income
0.45-9.21-13.745.64-62.820.14-3.34-0.282.48-0.44
Upgrade
Pretax Income
169.38114.8682.754.9462.66-91.2514.63-10.36-18.15
Upgrade
Income Tax
31.8323.4820.633.5413.72-3.27-2.44.81-7.58-7.45
Upgrade
Net Income
137.5591.3962.121.448.94-5.743.659.82-2.79-10.7
Upgrade
Net Income Growth
50.51%47.12%4327.37%-97.13%---62.86%---
Upgrade
Shares Outstanding (Basic)
48494847474646454542
Upgrade
Shares Outstanding (Diluted)
53525049504648484542
Upgrade
Shares Change
1.09%5.31%1.34%-1.57%7.57%-4.08%1.82%5.66%7.16%7.91%
Upgrade
EPS (Basic)
2.851.881.300.031.04-0.120.080.22-0.06-0.25
Upgrade
EPS (Diluted)
2.601.741.250.030.98-0.120.080.21-0.06-0.25
Upgrade
EPS Growth
49.43%39.20%4066.67%-96.94%---61.90%---
Upgrade
Free Cash Flow
145.3465.5770.5423.410.21-8.374.1117.18-5.320.55
Upgrade
Free Cash Flow Per Share
3.011.351.480.500.00-0.180.090.38-0.120.01
Upgrade
Gross Margin
54.49%49.87%45.63%40.97%40.92%36.31%37.68%40.83%30.75%24.35%
Upgrade
Operating Margin
30.57%21.54%15.96%3.13%-0.01%-2.93%-0.53%6.03%-2.74%-8.54%
Upgrade
Profit Margin
21.34%18.31%14.19%0.40%15.18%-1.95%1.52%3.85%-1.11%-5.08%
Upgrade
Free Cash Flow Margin
22.55%13.14%16.11%6.69%0.06%-2.84%1.71%6.73%-2.11%0.26%
Upgrade
Effective Tax Rate
18.79%20.44%24.93%71.62%21.90%--191.99%32.88%--
Upgrade
EBITDA
225.48144.03109.0929.4682.875.7715.0327.821.94-5.01
Upgrade
EBITDA Margin
34.99%28.86%24.92%8.42%25.71%1.96%6.26%10.90%0.77%-2.38%
Upgrade
Depreciation & Amortization
28.9527.3225.4624.1420.0814.5312.9512.1611.3112.53
Upgrade
EBIT
196.54116.7183.635.3262.78-8.762.0815.65-9.38-17.54
Upgrade
EBIT Margin
30.50%23.39%19.10%1.52%19.48%-2.97%0.86%6.13%-3.73%-8.33%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).